Thermo Fisher Scientific
$665.60Change from previous close: −1.40%Absolute change: −$9.45
Valuation
Data as of October 1, 2026
Valuation multiples
- Market cap
- $245.97B
- Enterprise value
- $288.21B
- P/E (trailing 12 months)
- 36.1
- Forward P/E
- 24.1
- PEG
- 2.02
- Price/book
- 4.67
- Price/sales
- 5.31
- EV/EBITDA
- 24.6
- EV/revenue
- 6.22
Profitability and growth
- Gross margin
- 41.0%
- Operating margin
- 18.8%
- Net margin
- 15.0%
- ROE
- 13.5%
- ROA
- 5.1%
- Revenue growth (year over year)
- 10.5%
- Earnings growth (year over year)
- 9.4%
Financial health
- Total cash
- $4.06B
- Total debt
- $42.55B
- Debt/equity
- 0.81
- Current ratio
- 1.55
- Quick ratio
- 1.01
Dividends
- Annual dividend per share
- $1.88
- Dividend yield
- 0.3%
- Payout ratio
- 9.7%
- Ex-dividend date
- September 15, 2026
Analysts and estimates
- Average price target
- $652.85
- Median price target
- $650.00
- High price target
- $780.00
- Low price target
- $520.00
- Number of analysts
- 26
- Consensus
- Buy
- Forward EPS
- $27.55
- EPS estimate, current year
- $25.13
Shares and trading
- Beta
- 0.85
- Average volume
- 2.05M
- Shares outstanding
- 369.75M
- Float
- 368.82M
- Institutional ownership
- 94.1%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 1.4%
- Short ratio (days)
- 2.87